WHO is­sues new guide­lines for gene edit­ing; Doud­na-backed Cari­bou launch­es its first al­lo­gene­ic CAR-T tri­al

4 years ago
News Briefing

Switch­ing fo­cus in the brain, re­searchers her­ald a pos­si­ble gene ther­a­py break­through in treat­ing an ul­tra-rare ...

4 years ago
R&D
Cell/Gene Tx

Branch­ing out from di­a­betes? No­vo Nordisk shells out the big bucks for Prothena's AT­TR amy­loi­do­sis pipeline

4 years ago
Deals

As 5 more biotechs file their IPOs, one Nas­daq of­fi­cial does­n't see mo­men­tum slow­ing down any­time soon

4 years ago
Financing

Biden sets a 45-day count­down for 'com­pre­hen­sive' plan to tack­le drug pric­ing — while cham­pi­oning some fa­mil­iar ...

4 years ago
Pharma

Covid-19 roundup: In­otrem loads up on French fund­ing to take sep­tic shock can­di­date to the next stage; Bel­gian woman ...

4 years ago
Coronavirus

Storm brews around Aduhelm as FDA re­quests probe; Dis­sect­ing pipeline dis­as­ters; Bob Nelsen is go­ing Re­al­ly Big; and ...

4 years ago
Weekly

Aim­ing to re­bound from blun­ders years ago, Celldex touts a Phase Ib win with sights set on Xo­lair

4 years ago
R&D

Astel­las and Seagen's Pad­cev wins full FDA ap­proval, notch­ing ex­pand­ed la­bel in tough-to-crack urothe­lial can­cer

4 years ago
Pharma
FDA+

Bay­er takes SGLT2 hope­fuls head on with FDA ap­proval for new kid­ney dis­ease drug

4 years ago
Pharma
FDA+

Janet Wood­cock calls for in­de­pen­dent in­ves­ti­ga­tion in­to Bio­gen and FDA re­la­tion­ships in un­prece­dent­ed move

4 years ago
FDA+

With TransCode go­ing pub­lic, in­dus­try sur­pass­es $10B IPO mark; Galect­in's in­hibitor shows PhIb suc­cess in can­cer ...

4 years ago
News Briefing

Flag­ship takes a rare knock as cell re­place­ment start­up based on Bob Langer tech gets slapped with clin­i­cal hold

4 years ago
FDA+

Great Danes: Two Nordic biotechs name their chief ex­ec­u­tives; Ax­el Hoos bids adieu to Glax­o­SmithK­line, be­comes CEO of ...

4 years ago
Peer Review

With Lenti­Glo­bin cleared by FDA, blue­bird lifts EU mar­ket­ing hold on gene ther­a­py us­ing the same de­liv­ery mech­a­nism

4 years ago
Cell/Gene Tx

Pelosi threat­ens to slide drug pric­ing re­form in­to Biden's bud­get bill, re­jects in­dus­try push­back that in­no­va­tion ...

4 years ago
Pharma

As Pfiz­er/BioN­Tech prep EUA fil­ing for Covid-19 boost­er, FDA, CDC tell Amer­i­cans they don't need one just yet

4 years ago
FDA+
Coronavirus

Ovid shuf­fles C-suite, lays off staff in wake of PhI­II An­gel­man syn­drome fail

4 years ago
People
R&D

Kick­ing the habit, Philip Mor­ris forges $1.5B deal to ac­quire Vec­tura in race to build a top in­haled-drug com­pa­ny

4 years ago
Deals

No­vo Seeds launch­es a new neu­ro biotech as Alzheimer's R&D booms

4 years ago
Financing

Of­ten-passed plant in Col­orado has a new own­er, who's al­ready op­er­at­ing near­by

4 years ago
R&D
Manufacturing

Mo­roc­can gov­ern­ment drops $500M in­to new Re­ci­pharm fill-fin­ish plant in big boost for African man­u­fac­tur­ing

4 years ago
Outsourcing
Manufacturing

Re­call re­port: Teva's chemother­a­py drug re­called af­ter in­ves­ti­ga­tors find par­tic­u­lates in­side vials

4 years ago
Manufacturing

Agenus to move Cal­i­for­nia op­er­a­tions to new bio­man­u­fac­tur­ing clus­ter in Va­cav­ille

4 years ago
Manufacturing
First page Previous page 678679680681682683684 Next page Last page
A service from the Financial Times